Published in J Am Acad Dermatol on September 09, 2009
Pooled analysis of the safety and tolerability of onabotulinumtoxinA in the treatment of chronic migraine. Eur J Neurol (2014) 1.47
Treating glabellar lines with botulinum toxin type A-hemagglutinin complex: a review of the science, the clinical data, and patient satisfaction. Clin Interv Aging (2010) 0.86
Global Aesthetics Consensus: Botulinum Toxin Type A-Evidence-Based Review, Emerging Concepts, and Consensus Recommendations for Aesthetic Use, Including Updates on Complications. Plast Reconstr Surg (2016) 0.82
Nonallergic Eyelid Edema After Botulinum Toxin Type A Injection: Case Report and Review of Literature. Medicine (Baltimore) (2015) 0.75
Enzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection. Am J Respir Crit Care Med (2005) 1.58
OnabotulinumtoxinA treatment of mild glabellar lines in repose. Dermatol Surg (2010) 1.40
A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol (2002) 1.39
Transmission dynamics of tuberculosis in Tarrant county, Texas. Am J Respir Crit Care Med (2002) 1.22
Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety. J Am Acad Dermatol (2007) 1.21
Meta-analysis of neutralizing antibody conversion with onabotulinumtoxinA (BOTOX®) across multiple indications. Mov Disord (2010) 1.15
Double-blind, placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines. Plast Reconstr Surg (2003) 1.09
Does directly observed therapy (DOT) reduce drug resistant tuberculosis? BMC Public Health (2011) 1.05
Use of mammographic screening by HIV-infected women in the Women's Interagency HIV Study (WIHS). Prev Med (2002) 1.03
Maternal prenatal exposure to nitrosatable drugs and childhood brain tumours. Int J Epidemiol (2003) 1.00
Double-blind, randomized, placebo-controlled, dose-response study of the safety and efficacy of botulinum toxin type A in subjects with crow's feet. Dermatol Surg (2005) 0.96
A review: dietary and endogenously formed N-nitroso compounds and risk of childhood brain tumors. Cancer Causes Control (2005) 0.96
Baseline characteristics of participants in the oral health component of the Women's Interagency HIV Study. Community Dent Oral Epidemiol (2004) 0.95
Prevalence of anal intraepithelial neoplasia defined by anal cytology screening and high-resolution anoscopy in a primary care population of HIV-infected men and women. Dis Colon Rectum (2011) 0.90
Estimation of radiographic doses in a case-control study of acute myelogenous leukemia. Health Phys (2003) 0.90
An international case-control study of adult diet and brain tumor risk: a histology-specific analysis by food group. Ann Epidemiol (2009) 0.89
Botulinum toxin type A (BOTOX) for treatment of migraine. Dis Mon (2002) 0.87
Cerebrospinal fluid sodium rhythms. Cerebrospinal Fluid Res (2010) 0.86
Innovative technology for the assisted delivery of intensive voice treatment (LSVT®LOUD) for Parkinson disease. Am J Speech Lang Pathol (2012) 0.86
Residential magnetic field exposure and breast cancer risk: a nested case-control study from a multiethnic cohort in Los Angeles County, California. Am J Epidemiol (2003) 0.85
Cerebrospinal fluid sodium increases in migraine. Headache (2006) 0.85
Executive function changes before memory in preclinical Alzheimer's pathology: a prospective, cross-sectional, case control study. PLoS One (2013) 0.84
Treatment of high-grade anal intraepithelial neoplasia with infrared coagulation in a primary care population of HIV-infected men and women. Dis Colon Rectum (2012) 0.80
ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration (ALLSTAR) Trial: Rationale and Design. Cell Transplant (2016) 0.77
Smoking and risk of acute myeloid leukemia in adults. Cancer Causes Control (2006) 0.75
Botulinum type A treatment: no evidence of increased risk of seizures in juvenile cerebral palsy. Clin Rehabil (2010) 0.75
Phospholipase C activity increases in cerebrospinal fluid from migraineurs in proportion to the number of comorbid conditions: a case-control study. J Headache Pain (2013) 0.75
Cerebrospinal fluid phospholipase C activity increases in migraine. Cephalalgia (2010) 0.75